| Pancreatic cancer chemoresistance to gemcitabine M Amrutkar, IP Gladhaug Cancers 9 (11), 157, 2017 | 462 | 2017 |
| Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells M Amrutkar, M Aasrum, CS Verbeke, IP Gladhaug BMC cancer 19, 1-16, 2019 | 105 | 2019 |
| Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH M Amrutkar, E Cansby, E Nuñez‐Durán, C Pirazzi, M Ståhlman, ... The FASEB Journal 29 (4), 1564-1576, 2015 | 78 | 2015 |
| Genetic disruption of protein kinase STK25 ameliorates metabolic defects in a diet-induced type 2 diabetes model M Amrutkar, E Cansby, U Chursa, E Nuñez-Durán, B Chanclón, ... Diabetes 64 (8), 2791-2804, 2015 | 62 | 2015 |
| Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans M Amrutkar, M Kern, E Nuñez-Durán, M Ståhlman, E Cansby, U Chursa, ... Diabetologia 59, 341-353, 2016 | 57 | 2016 |
| STK25 is a critical determinant in nonalcoholic steatohepatitis M Amrutkar, U Chursa, M Kern, E Nuñez‐Durán, M Ståhlman, S Sütt, ... The FASEB Journal 30 (10), 3628-3643, 2016 | 54 | 2016 |
| Overexpression of protein kinase STK25 in mice exacerbates ectopic lipid accumulation, mitochondrial dysfunction and insulin resistance in skeletal muscle U Chursa, E Nuñez-Durán, E Cansby, M Amrutkar, S Sütt, M Ståhlman, ... Diabetologia 60 (3), 553-567, 2017 | 51 | 2017 |
| Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice E Nuñez‐Durán, M Aghajan, M Amrutkar, S Sütt, E Cansby, SL Booten, ... Hepatology communications 2 (1), 69-83, 2018 | 46 | 2018 |
| Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high‐fat diet E Cansby, M Amrutkar, LM Holm, A Nerstedt, A Reyahi, E Stenfeldt, ... The FASEB Journal 27 (9), 3660-3671, 2013 | 46 | 2013 |
| Targeted delivery of Stk25 antisense oligonucleotides to hepatocytes protects mice against nonalcoholic fatty liver disease E Cansby, E Nuñez-Durán, E Magnusson, M Amrutkar, SL Booten, ... Cellular and Molecular Gastroenterology and Hepatology 7 (3), 597-618, 2019 | 43 | 2019 |
| Commonly used pancreatic stellate cell cultures differ phenotypically and in their interactions with pancreatic cancer cells D Lenggenhager, M Amrutkar, P Sántha, M Aasrum, JM Löhr, ... Cells 8 (1), 23, 2019 | 37 | 2019 |
| Pharmacological activation of AMPK suppresses inflammatory response evoked by IL-6 signalling in mouse liver and in human hepatocytes A Nerstedt, E Cansby, M Amrutkar, U Smith, M Mahlapuu Molecular and cellular endocrinology 375 (1-2), 68-78, 2013 | 36 | 2013 |
| Differential gemcitabine sensitivity in primary human pancreatic cancer cells and paired stellate cells is driven by heterogenous drug uptake and processing M Amrutkar, NT Vethe, CS Verbeke, M Aasrum, AV Finstadsveen, ... Cancers 12 (12), 3628, 2020 | 31 | 2020 |
| Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans E Cansby, NM Kulkarni, E Magnusson, Y Kurhe, M Amrutkar, A Nerstedt, ... The FASEB Journal 33 (9), 9974-9989, 2019 | 26 | 2019 |
| Partial hepatic resistance to IL-6-induced inflammation develops in type 2 diabetic mice, while the anti-inflammatory effect of AMPK is maintained E Cansby, A Nerstedt, M Amrutkar, EN Durán, U Smith, M Mahlapuu Molecular and cellular endocrinology 393 (1-2), 143-151, 2014 | 26 | 2014 |
| HPTLC estimation of cefixime and cloxacillin in tablet dosage form SJ Pawar, AP Kale, MP Amrutkar, JJ Jagade, NS Pore, AV Bhosale Asian journal of research in chemistry 3 (2), 299-301, 2010 | 25 | 2010 |
| Morphological heterogeneity in pancreatic cancer reflects structural and functional divergence P Sántha, D Lenggenhager, A Finstadsveen, L Dorg, K Tøndel, ... Cancers 13 (4), 895, 2021 | 24 | 2021 |
| Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease M Caputo, Y Kurhe, S Kumari, E Cansby, M Amrutkar, E Scandalis, ... The FASEB Journal 35 (5), 2021 | 21 | 2021 |
| Stellate cells aid growth-permissive metabolic reprogramming and promote gemcitabine chemoresistance in pancreatic cancer M Amrutkar, IP Gladhaug Cancers 13 (4), 601, 2021 | 19 | 2021 |
| STK25 regulates oxidative capacity and metabolic efficiency in adipose tissue S Sütt, E Cansby, A Paul, M Amrutkar, E Nunez-Duran, NM Kulkarni, ... Journal of Endocrinology 238 (3), 187-202, 2018 | 17 | 2018 |
Jan BorénInstitute of Medicine, Dept of Molecular and Clinical Medicine, University of Gothenburg, Sweden在 wlab.gu.se 的电子邮件经过验证
Jan BorénInstitute of Medicine, Dept of Molecular and Clinical Medicine, University of Gothenburg, Sweden在 wlab.gu.se 的电子邮件经过验证